MedTrace Logo

Brazilian Network for Lymphoma Registry

NCT02265497 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 550

Last updated 2017-08-18

No results posted yet for this study

Summary

Currently there are no official data concerning incidence, progression and prognosis of patients with lymphoma in Brazil.This project aims the establishment of a network of 12 Brazilian Institutions to implement a Lymphoma Registry (RELINFO) with the Brazilian National Cancer Institute (INCA) as the Coordinating Center.We intend to develop and implement a computerized system for data entry and information management of patients with lymphomas. This will enable create a virtual registry of demographic, clinical, epidemiological, histopathological, molecular, and therapeutic data. This clinical record must be linked to histopathological and molecular diagnosis, allowing institutions that work in the context of the public health system have access to new technologies for early cancer diagnosis.We expect is that this record reliably portrays the scene of lymphomas in our state and will become a management model that can be replicated at the national level. Thus, the implementation of RELINFO will strengthen the multidisciplinary diagnosis, promote the standardization of clinical record of patients with lymphomas and provide subsidies to cooperative research projects between participating institutions.

Conditions

Sponsors & Collaborators

  • Adriana Alves de Souza Scheliga

    collaborator UNKNOWN

  • Claudete Esteves Nogueira Pinto Klumb

    collaborator UNKNOWN

  • Ricardo de Sá Bigni

    collaborator UNKNOWN

  • Luciana Wernersbach Pinto

    collaborator UNKNOWN

  • Rocio Hassan

    collaborator UNKNOWN

  • Isabele Avila Small

    collaborator UNKNOWN

  • Monik Mariano Pinto

    collaborator UNKNOWN

  • Cecilia Ferreira da Silva

    collaborator UNKNOWN

  • Claudio Gustavo Stefanoff

    lead OTHER_GOV

Principal Investigators

  • Claudio Gustavo Stefanoff, Doctor · Instituto Nacional de Cancer, Brazil

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-03-31
Primary Completion
2018-12-31
Completion
2025-12-31

Countries

  • Brazil

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02265497 on ClinicalTrials.gov